Hall of Shame

[anonymous]

Bringing Innovation to Life!

Nemolizumab - developed by Chugai Pharma
Relabotulinum - royalties to Ipsen

Pipeline is completely empty. There's nothing at all. Where is the innovation???

 

[anonymous]

Flemming is delusional.

 

[anonymous]

Product pipeline is power. We have nothing.

 

[anonymous]

Our pipeline isn't promising and competitive threats on the horizon..... Time to go.

 

[anonymous]

Galderma is a bloated 3rd league business with no innovation or plan to drive growth. It’s like a giant ship at sea with a rudder and engine stuck on autopilot just sauntering along headed for the shoals.